SBI Securities’s Bionano Genomics BNGO Stock Holding History

SBI Securities’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$426	Buy	273 +27	+11%	+$34	﹤0.01%	3171
2026 Q2	$278	Buy	246 +12	+5%	+$14	﹤0.01%	3222
2026 Q1	$274	Buy	234 +10	+4%	+$13	﹤0.01%	3105
2025 Q4	$343	Sell	224 -10	-4%	-$17	﹤0.01%	3016
2025 Q3	$400	Sell	234 -47	-17%	-$149	﹤0.01%	3063
2025 Q2	$922	Buy	281 +19	+7%	+$71	﹤0.01%	2714
2025 Q1	$731	Buy	262 +110	+72%	+$720	﹤0.01%	2721
2024 Q4	$2.64K	Buy	+152	New	+$2.6K	﹤0.01%	2189

Other funds holding BNGO

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Carret Asset Management New York $1.14B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

SBI Securities's BNGO Position: Q3 2026 in Review

SBI Securities increased its Bionano Genomics (BNGO) stake by 11% in Q3 2026, buying an estimated $34 and bringing the position to 273 shares worth $426. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

SBI Securities first reported a position in BNGO in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.64K in Q4 2024. 9 funds tracked by Wall St. Rank hold BNGO as of Q3 2026.

SBI Securities held 273 shares of Bionano Genomics worth $426 as of Q3 2026.
SBI Securities bought 27 Bionano Genomics shares in Q3 2026, an estimated $34.
Bionano Genomics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3171 holding.
SBI Securities first reported a position in Bionano Genomics in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Bionano Genomics position peaked at $2.64K in Q4 2024.
9 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.